Development of lateral flow immunoassay system based on superparamagnetic nanobeads as labels for rapid quantitative detection of cardiac troponin I

Abstract In this study, superparamagnetic nanobeads (SPMNBs) were used as labels to establish a lateral flow immunoassay system for rapid, quantitative detection of cardiac troponin I (cTnI). First, the immunobeads were prepared by coupling monoclone antibody specific to cTnI onto SPMNBs. Then some factors which may influence the detection sensitivity of this lateral flow immunoassay system were studied, such as the amount of antibody immobilized in the Test line, sample volume and the amount of antibody per SPMNB. Finally, lateral flow test strips for detection of cTnI were established and applied to testing standard samples of different cTnI concentrations, which were also measured by Enzyme-linked Immunosorbent Assay (ELISA) in parallel. Furthermore, testing time and stability of magnetic signal were also investigated in this study. Results showed that this lateral flow test for cTnI had a high detection sensitivity of 0.01 ng/ml with a wide detection range of 5 orders of magnitude. The testing time was less than 15 min, and no significant decline of magnetic signal was observed in 140 days. Therefore, this lateral flow immunoassay system using SPMNB as labels will be a new point of care test (POCT) for rapid, quantitative detection of cardiac troponin I.

[1]  Fred S Apple,et al.  Evaluation of a point-of-care assay for cardiac markers for patients suspected of acute myocardial infarction. , 2004, Clinica chimica acta; international journal of clinical chemistry.

[2]  Zhen Yang,et al.  Cardiac markers and their point-of-care testing for diagnosis of acute myocardial infarction. , 2006, Clinical biochemistry.

[3]  Hongchen Gu,et al.  Development of high magnetization Fe3O4/polystyrene/silica nanospheres via combined miniemulsion/emulsion polymerization. , 2006, Journal of the American Chemical Society.

[4]  Cordula Grüttner,et al.  Improved properties of magnetic particles by combination of different polymer materials as particle matrix , 2001 .

[5]  Hong Xu,et al.  Developing a hybrid emulsion polymerization system to synthesize Fe3O4/polystyrene latexes with narrow size distribution and high magnetite content , 2007 .

[6]  Won-Bo Shim,et al.  Immunochromatography using colloidal gold-antibody probe for the detection of atrazine in water samples. , 2006, Journal of agricultural and food chemistry.

[7]  F. Apple,et al.  Point-of-care i-STAT cardiac troponin I for assessment of patients with symptoms suggestive of acute coronary syndrome. , 2006, Clinical chemistry.

[8]  J. Kasprzak,et al.  Heart-type fatty acid binding protein--a reliable marker of myocardial necrosis in a heterogeneous group of patients with acute coronary syndrome without persistent ST elevation. , 2008, Kardiologia polska.

[9]  A. Remppis,et al.  Improved troponin T ELISA specific for cardiac troponin T isoform: assay development and analytical and clinical validation. , 1997, Clinical chemistry.

[10]  A. Jaffe.  Chasing troponin: how low can you go if you can see the rise? , 2006, Journal of the American College of Cardiology.

[11]  Ji-Young Kim,et al.  Development of immunochromatography strip-test using nanocolloidal gold-antibody probe for the rapid detection of aflatoxin B1 in grain and feed samples. , 2007, Journal of microbiology and biotechnology.

[12]  B. Pau,et al.  Circulating cardiac troponin I in severe congestive heart failure. , 1997, Circulation.

[13]  G. Brogan,et al.  Cardiac marker point-of-care testing in the Emergency Department and Cardiac Care Unit. , 1998, Clinical chemistry.

[14]  M. Zahn,et al.  Magnetic fluids bibliography , 1980 .

[15]  F. Apple,et al.  Cardiac troponin-I is not expressed in fetal and healthy or diseased adult human skeletal muscle tissue. , 1995, Clinical chemistry.

[16]  Young Min Kim,et al.  Development of an ultrarapid one-step fluorescence immunochromatographic assay system for the quantification of microcystins. , 2003, Environmental science & technology.

[17]  F. Apple,et al.  Tissue specificity of cardiac troponin I, cardiac troponin T and creatine kinase-MB. , 1999, Clinica chimica acta; international journal of clinical chemistry.

[18]  Piia von Lode,et al.  Point-of-care immunotesting: approaching the analytical performance of central laboratory methods. , 2005 .

[19]  J. Ladenson,et al.  Development of monoclonal antibodies for an assay of cardiac troponin-I and preliminary results in suspected cases of myocardial infarction. , 1992, Clinical chemistry.